Ivermectin, the standard drug for treating river blindness (onchocerciasis), is causing genetic changes in the parasite that causes the disease, according to a new study by Roger Prichard (McGill University, Canada) and colleagues, published on August 30, 2007 in the open-access journal PLoS Neglected Tropical Diseases. These genetic changes have previously been linked with parasites becoming resistant to ivermectin.

In studying how neurotransmitters travel between cells -- by analysis of events in the dimensions of nanometers -- Cornell researchers have discovered that an electrical current thought to be present during that process does not, in fact, exist.

These results were reported July 22 in the online edition of the journal Nature Cell Biology by Cornell researchers Liang-Wei Gong and Manfred Lindau, applied and engineering physics, as well as their colleague Guillermo Alvarez de Toledo at the University of Seville, Spain.

Researchers have made synthetic lipids called pseudoceramides that are involved in skin cell growth and could be used in treating skin diseases in which skin cells grow abnormally.

Ceramides are lipids found in the outermost skin layer called the stratum corneum, which is made of dead skin cells and mainly serves as a physical barrier. Ceramides' main biological function is to control how skin cells grow and differentiate - a process through which skin cells become specialized.

In obese individuals, fat cells are bloated and inflamed because they receive too many nutrients, including lipids. In these cells, various components cannot work properly anymore and, instead, they activate new proteins to cope with the situation. One of the most challenged organelles in obese fat cells is a maze-like compartment called the endoplasmic reticulum (ER) that makes proteins and lipid droplets and senses the amount of nutrients that enter the cell.

Margaret F. Gregor and Gokhan S. Hotamisligil review current knowledge about how the ER works in fat cells and is modified in obesity. They show that when a fat cell receives too many nutrients, the ER is overwhelmed and triggers a process called the unfolded protein response (UPR).

Scientists have discovered that a lipid known to protect the heart from inflammation and to cause skin allergic reactions also reduces inflammation of the kidneys. The discovery could help devise new ways of treating inflammatory kidney diseases.

The lipid, called sphingosylphosphorylcholine (SPC), has been shown to cause an increase in urine production in the kidneys and an abnormal accumulation of salt in the urine. But how SPC works in the kidneys is not completely understood.

Andrea Huwiler and colleagues examined the various proteins activated by SPC in kidney cells and showed for the first time that SPC triggers proteins known to reduce inflammation.

Single-walled carbon nanotubes (SWCNTs) can kill bacteria like the common pathogen E. coli by severely damaging their cell walls, according to a recent report from Yale researchers in the American Chemical Society (ACS) journal Langmuir.

“We began the study out of concerns for the possible toxicity of nanotubes in aquatic environments and their presence in the food chain,” said Menachem Elimelech, professor and chair of chemical and environmental engineering at Yale and senior author on the paper.

Engineers at the University of Washington are working with Harborview doctors to create new emergency treatments right out of Star Trek: a tricorder type device using high-intensity focused ultrasound rays. This summer, researchers published the first experiment using ultrasound to seal punctured lungs.

"No one has ever looked at treating lungs with ultrasound," said Shahram Vaezy, a UW associate professor of bioengineering. Physicists were skeptical it would work because a lung is essentially a collection of air sacs, and air blocks transmission of ultrasound. But the new experiments show that punctures on the lung's surface, where injuries usually occur, heal with ultrasound therapy.

"The results are really impressive," Vaezy said.

A drug that shuts down a critical cell-signaling pathway in the most common and aggressive type of adult brain cancer successfully kills cancer stem cells thought to fuel tumor growth and help cancers evade drug and radiation therapy, a Johns Hopkins study shows.

In a series of laboratory and animal experiments, Johns Hopkins scientists blocked the signaling system, known as Hedgehog, with an experimental compound called cyclopamine to explore the blockade’s effect on cancer stem cells that populate glioblastoma multiforme. Cyclopamine has long been known to inhibit Hedgehog signaling.

Yes, last week science said Song Debunked: Breaking Up Actually Not So Hard To Do but it's a new week and this is a different study.

They use the same song example, though.

Dr. Bronwen Lichtenstein, UA assistant professor of criminal justice who specializes in women’s issues, recently completed a study of the health risks women over age 35 faced when they returned to the dating scene after the breakup of a long-term relationship.

Lichtenstein was investigating the theory that after an older woman leaves a long-term relationship she may make risky dating choices.

Health food is extremely popular in America yet obesity levels continue to rise. A new study in the Journal of Consumer Research explains that paradox.

It turns out that when consumers see a healthy choice, be it drinks, deserts or food, they end up consuming 131% more calories.

“In our black and white view, most food is good or not good,” explain Pierre Chandon (INSEAD, France) and Brian Wansink (Cornell University). “When we see a fast-food restaurant like Subway advertising its low-calorie sandwiches, we think, ‘It’s OK: I can eat a sandwich there and then have a high-calorie dessert,’ when, in fact, some Subway sandwiches contain more calories than a Big Mac.”